0001437749-22-028438.txt : 20221205
0001437749-22-028438.hdr.sgml : 20221205
20221205173004
ACCESSION NUMBER: 0001437749-22-028438
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221121
FILED AS OF DATE: 20221205
DATE AS OF CHANGE: 20221205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunin Jeffrey
CENTRAL INDEX KEY: 0001738782
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33678
FILM NUMBER: 221445957
MAIL ADDRESS:
STREET 1: 4346 BELGIUM BLVD NW
CITY: RIVERSIDE
STATE: MO
ZIP: 64150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 2000 POWELL STREET, SUITE 1150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4/A
1
rdgdoc.xml
FORM 4
X0306
4/A
2022-11-21
2022-11-23
0001389545
NovaBay Pharmaceuticals, Inc.
NBY
0001738782
Kunin Jeffrey
C/O NOVABAY PHARMACEUTICALS, INC.
2000 POWELL STREET, SUITE 1150
EMERYVILLE
CA
94608
1
President, DERMAdoctor, LLC
Common Stock
2022-11-21
4
S
0
5960
2.10490
D
1
I
See footnote
On November 15, 2022, the common stock of NovaBay Pharmaceuticals, Inc. split 1-for-35, and is reflected accordingly in the number of shares sold.
This transaction was executed in multiple trades at prices ranging from $2.09 to $2.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The original Form 4, filed on November 23, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that the reporting person beneficially owned no shares following the reported transaction when in fact the reporting person beneficially owned one share following the reported transaction.
By The Audrey G. Kunin Trust in which the reporting person's spouse serves as the trustee and has investment control.
/s/ Jeffrey Kunin
2022-12-05